Dingli Dai currently serves as an Academic Alliance Manager at AstraZeneca since July 2024. Previously, Dingli held the position of Director of Business Development at Jointown Pharmaceutical Group from November 2023 to July 2024 and worked as a Senior Investment Manager at 科兴生物制药股份有限公司 from March 2022 to October 2023. Prior experience includes business development roles at GrandPharma (China) Co. Ltd and Cibiltech, as well as a research associate position at Institut Curie where a PhD thesis was completed focusing on protein-chromatin interactions. Early career experience includes roles at Oslo University Hospital and an R&D internship at Wuhan Biotgene Co., Ltd. Dingli holds a PhD in Life Sciences from Université Paris-Saclay and a Master of Science in Biochemistry and Molecular Biology from the University of Oslo.
This person is not in any teams
This person is not in any offices